Medical Evaluation of the Patient Undergoing Noncardiac Surgery¶
Chapter 492 | Part 19: Consultative Medicine
KEY CLINICAL POINTS¶
- Preoperative cardiac risk assessment is critical to reduce perioperative cardiovascular complications using tools like RCRI and NSQIP risk calculator.
- Functional capacity assessment (METs) and spirometry guide noninvasive testing decisions for high-risk patients.
- Perioperative management includes beta-blockers, statins, antiplatelet agents, and thromboprophylaxis tailored to risk stratification.
- Pulmonary risk factors (e.g., COPD, obesity, ASA ≥ 2) require preoperative optimization and postoperative pulmonary hygiene.
- Severe aortic stenosis may permit noncardiac surgery in selected patients with careful risk-benefit evaluation.
1. DEFINITION & OVERVIEW¶
Cardiovascular and pulmonary complications remain major causes of morbidity/mortality in noncardiac surgery. Preoperative evaluation aims to stratify risk, guide perioperative management, and prevent adverse events. The goal is to balance risk reduction with avoiding unnecessary testing.
Table 492-1 Standardized Preoperative Questionnaire¶
| Question | Details |
|---|---|
| 1. Age, weight, height | |
| 2. Age ‡55 (female) or ‡45 (male)? | If ‡70, additional risk |
| 3. Anticoagulant use? | |
| 4. Heart-related conditions? | Heart disease, MI, angina, arrhythmia, HF |
| 5. Comorbidities? | RA, kidney/liver disease, diabetes |
| 6. Dyspnea when lying flat? | |
| 7. Oxygen therapy? | |
| 8. Chronic cough with discharge? | |
| 9. Lung disease? | |
| 10. Family history of anesthesia complications? | |
| 11. Pregnancy (female)? | Pregnancy test required |
1.1 Preoperative Risk Assessment¶
Standardized questionnaires (Table 492-1) identify intermediate/high-risk patients. Functional capacity (METs) and spirometry thresholds (Table 492-3) guide noninvasive testing decisions.
1.2 Risk Stratification Tools¶
RCRI (Table 492-2) and NSQIP risk calculator estimate 30-day MACE risk. RCRI assigns 1 point per predictor (e.g., ischemic heart disease, CHF, diabetes, renal insufficiency).
2. EPIDEMIOLOGY¶
Cardiovascular complications account for 10-15% of perioperative mortality. Risk increases with age, comorbidities (e.g., diabetes, renal insufficiency), and high-risk surgeries (e.g., vascular, thoracic).
2.1 Risk Factors¶
Age ≥ 65, ASA ≥ 2, chronic lung disease, obesity, and functional status <4 METs are independent predictors of adverse outcomes.
3. ETIOLOGY & PATHOPHYSIOLOGY¶
Perioperative cardiac events result from ischemia, arrhythmias, and hemodynamic stress. Risk factors include preexisting CAD, anesthetic-induced myocardial depression, and surgical stress.
3.1 Mechanisms¶
Ischemia from reduced coronary perfusion, arrhythmias from autonomic imbalance, and hemodynamic instability from fluid shifts and anesthetic agents.
4. CLINICAL FEATURES¶
Symptoms include chest pain, dyspnea, syncope, and arrhythmias. Signs may include hypotension, tachycardia, and ECG changes (e.g., ST elevation, new LBBB).
4.1 Complications¶
Major adverse cardiac events (MACE): MI, pulmonary edema, ventricular fibrillation, cardiac arrest. Pulmonary complications: pneumonia, atelectasis, ARDS.
5. DIFFERENTIAL DIAGNOSIS¶
Acute coronary syndrome, pulmonary embolism, arrhythmias, and anesthetic-related complications must be differentiated from baseline cardiac disease.
5.1 Key Differentiators¶
Acute MI vs. stable angina; pulmonary embolism vs. COPD exacerbation; arrhythmias vs. electrolyte disturbances.
6. INVESTIGATIONS & DIAGNOSIS¶
Preoperative ECG, spirometry, and risk indices (RCRI, NSQIP) guide diagnosis. Noninvasive testing (stress echo, MPI) is indicated for poor functional capacity.
Table 492-2 Clinical Markers Included in the Revised Cardiac Risk Index¶
| Category | Markers |
|---|---|
| High-Risk Surgical Procedures | Vascular surgery, major intraperitoneal/thoracic procedures |
| Ischemic Heart Disease | History of MI, current ischemic angina, positive stress test |
| Congestive Heart Failure | Left ventricular failure, paroxysmal nocturnal dyspnea |
| Cerebrovascular Disease | TIA, stroke history |
| Diabetes Mellitus | Insulin-treated diabetes |
| Chronic Renal Insufficiency | Serum creatinine >2.0 mg/dL |
6.1 Diagnostic Criteria¶
RCRI assigns 1 point per predictor (e.g., ischemic heart disease, CHF, diabetes, renal insufficiency). NSQIP calculator estimates 30-day MACE risk.
7. MANAGEMENT & TREATMENT¶
Perioperative management includes beta-blockers, statins, antiplatelet agents, and thromboprophylaxis. Nonpharmacologic strategies include smoking cessation and pulmonary hygiene.
Table 492-4 Gradation of Mortality Risk of Common Noncardiac Surgical Procedures¶
| Risk Category | Examples |
|---|---|
| Higher | Emergent major operations, aortic surgery, prolonged procedures |
| Intermediate | Major thoracic/abdominal surgery, carotid endarterectomy |
| Lower | Eye/skin surgery, endoscopic procedures |
7.1 Medications¶
Beta-blockers (avoid on surgery day), statins (continue pre/post-op), antiplatelets (manage stent timing), and ACE inhibitors (continue if stable).
7.2 Thromboprophylaxis¶
Low-dose heparin or direct oral anticoagulants for moderate-risk patients. Graduated compression stockings as adjunct.
8. PROGNOSIS & COMPLICATIONS¶
RCRI predicts 0.4-11% risk of MACE based on predictors. Pulmonary complications (pneumonia, atelectasis) occur in 5-10% of patients.
8.1 Risk Modification¶
Preoperative optimization (smoking cessation, weight loss), intraoperative ventilation management, and postoperative mobilization.
9. SPECIAL CONSIDERATIONS¶
Pregnancy requires modified risk assessment (Table 492-1). Elderly patients face higher risks of hemodynamic instability. Diabetic patients need glucose control (100-180 mg/dL).
9.1 Pregnancy¶
Pregnancy test required. Avoid elective surgery in first trimester. Monitor for preeclampsia and fetal complications.
10. KEY POINTS & CLINICAL PEARLS¶
Use RCRI and NSQIP for risk stratification. Avoid beta-blockers on surgery day. Continue statins and antiplatelets unless contraindicated. Optimize pulmonary function preoperatively. Thromboprophylaxis should be tailored to risk.